Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Effects of individual and complex ciprofloxacin, fullerene C60, and ZnO nanoparticles on sludge digestion: Methane production, metabolism, and microbial community.

Zhao L, Ji Y, Sun P, Li R, Xiang F, Wang H, Ruiz-Martinez J, Yang Y.

Bioresour Technol. 2018 Nov;267:46-53. doi: 10.1016/j.biortech.2018.07.024. Epub 2018 Jul 7.

PMID:
30014997
2.

LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.

Muñoz-Lopetegi A, López-González FJ, Rodríguez-Osorio X, Pato Pato A, Bellas Lamas P, Abella-Corral J, Castro Vilanova MD, Garea MJ, Gil López JA, Ruiz-Martínez J, Poza JJ.

Epilepsy Res. 2018 Sep;145:51-54. doi: 10.1016/j.eplepsyres.2018.05.011. Epub 2018 May 31.

PMID:
29890341
3.

Not always is an infection.

García Martínez E, Ruíz Martínez J, Hernández-Gil Sánchez J, Brufau Redondo C, Poblet Martínez E.

Med Clin (Barc). 2018 Mar 6. pii: S0025-7753(18)30056-3. doi: 10.1016/j.medcli.2018.01.009. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29523339
4.

[Myths and evidence on the use of botulinum toxin: neuropharmacology and dystonia].

Garcia-Ruiz PJ, Sanz-Cartagena P, Martinez-Castrillo JC, Ares-Pensado B, Aviles-Olmos I, Blazquez-Estrada M, Fanjul-Arbos S, Garcia-Caldentey J, Gazulla J, Gutierrez-Garcia J, Huete-Anton B, Lucas-Rodenas C, Luquin MR, Martinez-Torres I, Medialdea-Natera P, Mendoza-Rodriguez A, Mir-Rivera P, Posada IJ, Ruiz-Martinez J, Sanchez-Alonso P, Trejo-Gabriel Y Galan JM, Vela L, Pena-Segura JL.

Rev Neurol. 2018 Mar 1;66(5):163-172. Spanish.

5.

More than a cyst in the head.

García Martínez E, Ruíz Martínez J, Hernández Gómez TA, Hernández-Gil Sánchez J, Brufau Redondo C.

Med Clin (Barc). 2018 Oct 23;151(8):338. doi: 10.1016/j.medcli.2017.11.049. Epub 2018 Feb 3. English, Spanish. No abstract available.

PMID:
29398007
6.

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.

Madero-Pérez J, Fdez E, Fernández B, Lara Ordóñez AJ, Blanca Ramírez M, Gómez-Suaga P, Waschbüsch D, Lobbestael E, Baekelandt V, Nairn AC, Ruiz-Martínez J, Aiastui A, López de Munain A, Lis P, Comptdaer T, Taymans JM, Chartier-Harlin MC, Beilina A, Gonnelli A, Cookson MR, Greggio E, Hilfiker S.

Mol Neurodegener. 2018 Jan 23;13(1):3. doi: 10.1186/s13024-018-0235-y.

7.

Influence of the Reaction Temperature on the Nature of the Active and Deactivating Species During Methanol-to-Olefins Conversion over H-SAPO-34.

Borodina E, Sharbini Harun Kamaluddin H, Meirer F, Mokhtar M, Asiri AM, Al-Thabaiti SA, Basahel SN, Ruiz-Martinez J, Weckhuysen BM.

ACS Catal. 2017 Aug 4;7(8):5268-5281. doi: 10.1021/acscatal.7b01497. Epub 2017 Jul 12.

8.

Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson disease.

Ruiz-Martínez J, Azcona LJ, Bergareche A, Martí-Massó JF, Paisán-Ruiz C.

Neurol Genet. 2017 Aug 2;3(5):e177. doi: 10.1212/NXG.0000000000000177. eCollection 2017 Oct.

9.

Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.

Lee AJ, Wang Y, Alcalay RN, Mejia-Santana H, Saunders-Pullman R, Bressman S, Corvol JC, Brice A, Lesage S, Mangone G, Tolosa E, Pont-Sunyer C, Vilas D, Schüle B, Kausar F, Foroud T, Berg D, Brockmann K, Goldwurm S, Siri C, Asselta R, Ruiz-Martinez J, Mondragón E, Marras C, Ghate T, Giladi N, Mirelman A, Marder K; Michael J. Fox LRRK2 Cohort Consortium.

Mov Disord. 2017 Oct;32(10):1432-1438. doi: 10.1002/mds.27059. Epub 2017 Jun 22.

10.

Insights into the Activity and Deactivation of the Methanol-to-Olefins Process over Different Small-Pore Zeolites As Studied with Operando UV-vis Spectroscopy.

Goetze J, Meirer F, Yarulina I, Gascon J, Kapteijn F, Ruiz-Martínez J, Weckhuysen BM.

ACS Catal. 2017 Jun 2;7(6):4033-4046. doi: 10.1021/acscatal.6b03677. Epub 2017 May 16.

11.

Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.

Delgado-Alvarado M, Gago B, Gorostidi A, Jiménez-Urbieta H, Dacosta-Aguayo R, Navalpotro-Gómez I, Ruiz-Martínez J, Bergareche A, Martí-Massó JF, Martínez-Lage P, Izagirre A, Rodríguez-Oroz MC.

Mov Disord. 2017 Jul;32(7):1066-1073. doi: 10.1002/mds.27001. Epub 2017 May 26.

PMID:
28548309
12.

Progressive changes in non-coding RNA profile in leucocytes with age.

Muñoz-Culla M, Irizar H, Gorostidi A, Alberro A, Osorio-Querejeta I, Ruiz-Martínez J, Olascoaga J, López de Munain A, Otaegui D.

Aging (Albany NY). 2017 Apr;9(4):1202-1218. doi: 10.18632/aging.101220.

13.

Effect of Feedstock and Catalyst Impurities on the Methanol-to-Olefin Reaction over H-SAPO-34.

Vogt C, Weckhuysen BM, Ruiz-Martínez J.

ChemCatChem. 2017 Jan 9;9(1):183-194. doi: 10.1002/cctc.201600860. Epub 2016 Nov 29.

14.

Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease.

Brockmann K, Schulte C, Schneiderhan-Marra N, Apel A, Pont-Sunyer C, Vilas D, Ruiz-Martinez J, Langkamp M, Corvol JC, Cormier F, Knorpp T, Joos TO, Bernard A, Gasser T, Marras C, Schüle B, Aasly JO, Foroud T, Marti-Masso JF, Brice A, Tolosa E, Berg D, Maetzler W.

Eur J Neurol. 2017 Feb;24(2):427-e6. doi: 10.1111/ene.13223.

PMID:
28102045
15.

Prevalence and Genetic Diversity of Avipoxvirus in House Sparrows in Spain.

Ruiz-Martínez J, Ferraguti M, Figuerola J, Martínez-de la Puente J, Williams RA, Herrera-Dueñas A, Aguirre JI, Soriguer R, Escudero C, Moens MA, Pérez-Tris J, Benítez L.

PLoS One. 2016 Dec 22;11(12):e0168690. doi: 10.1371/journal.pone.0168690. eCollection 2016.

16.

Erythematous infiltrated plaques as an onset manifestation of rapidly evolving lymphoma.

Dorado Fernández M, Ruiz Martínez J, Pastor Quirante F, Hernández-Gil Sánchez J.

Med Clin (Barc). 2017 Aug 10;149(3):e13. doi: 10.1016/j.medcli.2016.10.023. Epub 2016 Nov 30. English, Spanish. No abstract available.

PMID:
27914677
17.

[Painful erythematous macular lesion in the ankle of a young woman].

Dorado-Fernández M, Brufau-Redondo C, Pastor-Quirante F, Ruiz-Martínez J, Hernández-Gil Sánchez J.

Semergen. 2017 May - Jun;43(4):338-340. doi: 10.1016/j.semerg.2016.07.011. Epub 2016 Sep 23. Spanish. No abstract available.

PMID:
27670735
18.

Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.

Gorostidi A, Martí-Massó JF, Bergareche A, Rodríguez-Oroz MC, López de Munain A, Ruiz-Martínez J.

Mol Diagn Ther. 2016 Oct;20(5):481-91. doi: 10.1007/s40291-016-0216-1.

PMID:
27294386
19.

Inflammatory profile in LRRK2-associated prodromal and clinical PD.

Brockmann K, Apel A, Schulte C, Schneiderhan-Marra N, Pont-Sunyer C, Vilas D, Ruiz-Martinez J, Langkamp M, Corvol JC, Cormier F, Knorpp T, Joos TO, Gasser T, Schüle B, Aasly JO, Foroud T, Marti-Masso JF, Brice A, Tolosa E, Marras C, Berg D, Maetzler W.

J Neuroinflammation. 2016 May 24;13(1):122. doi: 10.1186/s12974-016-0588-5.

20.

Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.

Marras C, Alcalay RN, Caspell-Garcia C, Coffey C, Chan P, Duda JE, Facheris MF, Fernández-Santiago R, Ruíz-Martínez J, Mestre T, Saunders-Pullman R, Pont-Sunyer C, Tolosa E, Waro B; LRRK2 Cohort Consortium.

Mov Disord. 2016 Aug;31(8):1192-202. doi: 10.1002/mds.26614. Epub 2016 Apr 19.

PMID:
27091104
21.

Fluoride-assisted synthesis of bimodal microporous SSZ-13 zeolite.

Zhu X, Kosinov N, Hofmann JP, Mezari B, Qian Q, Rohling R, Weckhuysen BM, Ruiz-Martínez J, Hensen EJ.

Chem Commun (Camb). 2016 Feb 21;52(15):3227-30. doi: 10.1039/c6cc00201c.

PMID:
26810114
22.

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.

Bergareche A, Rodríguez-Oroz MC, Estanga A, Gorostidi A, López de Munain A, Castillo-Triviño T, Ruiz-Martínez J, Mondragón E, Gaig C, Lomeña F, Sarasqueta C, Tolosa E, Martí-Massó JF.

Mov Disord. 2016 Mar;31(3):335-43. doi: 10.1002/mds.26478. Epub 2015 Dec 21.

PMID:
26686514
23.

[Rapidly evolving tinea corporis].

Dorado Fernández M, Salas García T, López Gómez A, Arcas MI, Ruiz Martínez J, Hernández-Gil Sánchez J.

Rev Iberoam Micol. 2016 Jan-Mar;33(1):59-60. doi: 10.1016/j.riam.2015.07.002. Epub 2015 Nov 25. Spanish. No abstract available.

PMID:
26626809
24.

Effects of Coke Deposits on the Catalytic Performance of Large Zeolite H-ZSM-5 Crystals during Alcohol-to-Hydrocarbon Reactions as Investigated by a Combination of Optical Spectroscopy and Microscopy.

Nordvang EC, Borodina E, Ruiz-Martínez J, Fehrmann R, Weckhuysen BM.

Chemistry. 2015 Nov 23;21(48):17324-35. doi: 10.1002/chem.201503136. Epub 2015 Oct 14.

25.

SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy.

Bergareche A, Bednarz M, Sánchez E, Krebs CE, Ruiz-Martinez J, De La Riva P, Makarov V, Gorostidi A, Jurkat-Rott K, Marti-Masso JF, Paisán-Ruiz C.

Hum Mol Genet. 2015 Dec 15;24(24):7111-20. doi: 10.1093/hmg/ddv410. Epub 2015 Oct 1.

26.

SORT1 Mutation Resulting in Sortilin Deficiency and p75(NTR) Upregulation in a Family With Essential Tremor.

Sánchez E, Bergareche A, Krebs CE, Gorostidi A, Makarov V, Ruiz-Martinez J, Chorny A, Lopez de Munain A, Marti-Masso JF, Paisán-Ruiz C.

ASN Neuro. 2015 Aug 21;7(4). pii: 1759091415598290. doi: 10.1177/1759091415598290. Print 2015 Jul-Aug.

27.

Daylight photodynamic therapy.

Salas-García T, López-Gómez A, Dorado-Fernández M, Ruiz-Martínez J.

Actas Dermosifiliogr. 2015 Oct;106(8):672-3. doi: 10.1016/j.ad.2015.05.002. Epub 2015 Jun 29. Review. English, Spanish. No abstract available.

PMID:
26138286
28.

GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment.

Ruiz-Martinez J, Krebs CE, Makarov V, Gorostidi A, Martí-Massó JF, Paisán-Ruiz C.

J Hum Genet. 2015 Oct;60(10):637-40. doi: 10.1038/jhg.2015.69. Epub 2015 Jul 2.

29.

Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations.

Tijero B, Gabilondo I, Lezcano E, Teran-Villagrá N, Llorens V, Ruiz-Martinez J, Marti-Masso JF, Carmona M, Luquin MR, Berganzo K, Fernandez I, Fernandez M, Zarranz JJ, Gómez-Esteban JC.

Parkinsonism Relat Disord. 2015 Jul;21(7):717-22. doi: 10.1016/j.parkreldis.2015.04.012. Epub 2015 Apr 23.

PMID:
25960264
30.

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.

JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.

31.

Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI, Alcalay RN, Marder KS, Clark LN, Gaig C, Tolosa E, Ruiz-Martínez J, Marti-Masso JF, Ferrer I, López de Munain A, Goldman SM, Schüle B, Langston JW, Aasly JO, Giordana MT, Bonifati V, Puschmann A, Canesi M, Pezzoli G, Maues De Paula A, Hasegawa K, Duyckaerts C, Brice A, Stoessl AJ, Marras C.

JAMA Neurol. 2015 Jan;72(1):100-5. doi: 10.1001/jamaneurol.2014.2704.

32.

Catalytic dehydrogenation of light alkanes on metals and metal oxides.

Sattler JJ, Ruiz-Martinez J, Santillan-Jimenez E, Weckhuysen BM.

Chem Rev. 2014 Oct 22;114(20):10613-53. doi: 10.1021/cr5002436. Epub 2014 Aug 27. No abstract available.

PMID:
25163050
33.

Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.

Estanga A, Rodriguez-Oroz MC, Ruiz-Martinez J, Barandiaran M, Gorostidi A, Bergareche A, Mondragon E, Lopez de Munain A, Marti-Masso JF.

Parkinsonism Relat Disord. 2014 Oct;20(10):1097-100. doi: 10.1016/j.parkreldis.2014.07.005. Epub 2014 Jul 30.

PMID:
25127457
34.

Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants.

Alcalay RN, Aasly J, Berg D, Bressman S, Brice A, Brockmann K, Chan P, Clark L, Cormier F, Corvol JC, Durr A, Facheris M, Farrer M, Foroud TM, Gasser T, Giladi N, Halter C, Lang A, Langston JW, Marras C, Marti-Masso JF, Ruiz Martinez J, Mejia-Santana H, Mirelman A, Pont-Sunyer C, Orr-Urtreger A, Raymond D, Saunders-Pullman R, Schüle B, Tanner C, Tolosa E, Urkowitz A, Vilas D, Wise A, Marder K.

Genet Med. 2014 Aug;16(8):644-5. doi: 10.1038/gim.2014.55. No abstract available.

35.

Epitope Mapping of Antibodies to Alpha-Synuclein in LRRK2 Mutation Carriers, Idiopathic Parkinson Disease Patients, and Healthy Controls.

Alvarez-Castelao B, Gorostidi A, Ruíz-Martínez J, López de Munain A, Castaño JG.

Front Aging Neurosci. 2014 Jul 15;6:169. doi: 10.3389/fnagi.2014.00169. eCollection 2014.

36.

[Functional neuroimaging in the diagnosis of patients with Parkinsonism: Update and recommendations for clinical use].

Arbizu J, Luquin MR, Abella J, de la Fuente-Fernández R, Fernandez-Torrón R, García-Solís D, Garrastachu P, Jiménez-Hoyuela JM, Llaneza M, Lomeña F, Lorenzo-Bosquet C, Martí MJ, Martinez-Castrillo JC, Mir P, Mitjavila M, Ruiz-Martínez J, Vela L.

Rev Esp Med Nucl Imagen Mol. 2014 Jul-Aug;33(4):215-26. doi: 10.1016/j.remn.2014.02.001. Epub 2014 Apr 14. Review. Spanish.

37.

Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.

Ruiz-Martínez J, de la Riva P, Rodríguez-Oroz MC, Mondragón Rezola E, Bergareche A, Gorostidi A, Gago B, Estanga A, Larrañaga N, Sarasqueta C, López de Munain A, Martí Massó JF.

Mov Disord. 2014 May;29(6):750-5. doi: 10.1002/mds.25778. Epub 2013 Dec 19.

PMID:
24357540
38.

The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism.

Martí-Massó JF, Bergareche A, Makarov V, Ruiz-Martinez J, Gorostidi A, López de Munain A, Poza JJ, Striano P, Buxbaum JD, Paisán-Ruiz C.

J Mol Med (Berl). 2013 Dec;91(12):1399-406. doi: 10.1007/s00109-013-1075-4. Epub 2013 Aug 20.

39.

Single-particle spectroscopy on large SAPO-34 crystals at work: methanol-to-olefin versus ethanol-to-olefin processes.

Qian Q, Ruiz-Martínez J, Mokhtar M, Asiri AM, Al-Thabaiti SA, Basahel SN, van der Bij HE, Kornatowski J, Weckhuysen BM.

Chemistry. 2013 Aug 19;19(34):11204-15. doi: 10.1002/chem.201300540. Epub 2013 Jul 23.

PMID:
23881641
40.

Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.

González-Aramburu I, Sánchez-Juan P, Jesús S, Gorostidi A, Fernández-Juan E, Carrillo F, Sierra M, Gómez-Garre P, Cáceres-Redondo MT, Berciano J, Ruiz-Martínez J, Combarros O, Mir P, Infante J.

Mov Disord. 2013 Oct;28(12):1737-40. doi: 10.1002/mds.25507. Epub 2013 May 27.

PMID:
23712608
41.

Correlating metal poisoning with zeolite deactivation in an individual catalyst particle by chemical and phase-sensitive X-ray microscopy.

Ruiz-Martínez J, Beale AM, Deka U, O'Brien MG, Quinn PD, Mosselmans JF, Weckhuysen BM.

Angew Chem Int Ed Engl. 2013 Jun 3;52(23):5983-7. doi: 10.1002/anie.201210030. Epub 2013 Apr 24.

42.

Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers.

Gorostidi A, Bergareche A, Ruiz-Martínez J, Martí-Massó JF, Cruz M, Varghese S, Qureshi MM, Alzahmi F, Al-Hayani A, López de Munáin A, El-Agnaf OM.

PLoS One. 2012;7(12):e52312. doi: 10.1371/journal.pone.0052312. Epub 2012 Dec 27.

43.

Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene.

Tijero B, Gómez-Esteban JC, Lezcano E, Fernández-González C, Somme J, Llorens V, Martínez A, Ruiz-Martínez J, Foncea N, Escalza I, Berganzo K, Aniel-Quiroga MA, Ruiz V, Terán N, Kaufmann H, Zarranz JJ.

Parkinsonism Relat Disord. 2013 Jan;19(1):95-100. doi: 10.1016/j.parkreldis.2012.08.001. Epub 2012 Sep 19.

PMID:
23000061
44.

Ethanol steam reforming on Ni/Al2O3 catalysts: effect of the addition of Zn and Pt.

Buitrago-Sierra R, Ruiz-Martínez J, Serrano-Ruiz JC, Rodríguez-Reinoso F, Sepúlveda-Escribano A.

J Colloid Interface Sci. 2012 Oct 1;383(1):148-54. doi: 10.1016/j.jcis.2012.06.026. Epub 2012 Jun 20.

PMID:
22796067
45.

Integrated laser and electron microscopy correlates structure of fluid catalytic cracking particles to Brønsted acidity.

Karreman MA, Buurmans IL, Geus JW, Agronskaia AV, Ruiz-Martínez J, Gerritsen HC, Weckhuysen BM.

Angew Chem Int Ed Engl. 2012 Feb 6;51(6):1428-31. doi: 10.1002/anie.201106651. Epub 2011 Dec 23. No abstract available.

PMID:
22213229
46.

Effect of support and pre-treatment conditions on Pt-Sn catalysts: application to nitrate reduction in water.

Soares OS, Jardim EO, Reyes-Carmona A, Ruiz-Martínez J, Silvestre-Albero J, Rodríguez-Castellón E, Orfão JJ, Sepúlveda-Escribano A, Pereira MF.

J Colloid Interface Sci. 2012 Mar 1;369(1):294-301. doi: 10.1016/j.jcis.2011.11.059. Epub 2011 Dec 6.

PMID:
22196343
47.

Staining of fluid-catalytic-cracking catalysts: localising Brønsted acidity within a single catalyst particle.

Buurmans IL, Ruiz-Martínez J, van Leeuwen SL, van der Beek D, Bergwerff JA, Knowles WV, Vogt ET, Weckhuysen BM.

Chemistry. 2012 Jan 23;18(4):1094-101. doi: 10.1002/chem.201102949. Epub 2011 Dec 9.

PMID:
22161809
48.

Catalytic activity in individual cracking catalyst particles imaged throughout different life stages by selective staining.

Buurmans IL, Ruiz-Martínez J, Knowles WV, van der Beek D, Bergwerff JA, Vogt ET, Weckhuysen BM.

Nat Chem. 2011 Sep 18;3(11):862-7. doi: 10.1038/nchem.1148.

PMID:
22024882
49.

Exome sequencing identifies GCDH (glutaryl-CoA dehydrogenase) mutations as a cause of a progressive form of early-onset generalized dystonia.

Marti-Masso JF, Ruiz-Martínez J, Makarov V, López de Munain A, Gorostidi A, Bergareche A, Yoon S, Buxbaum JD, Paisán-Ruiz C.

Hum Genet. 2012 Mar;131(3):435-42. doi: 10.1007/s00439-011-1086-6. Epub 2011 Sep 13.

PMID:
21912879
50.

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Ruiz-Martínez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodríguez F, Bergareche A, Moreno F, López de Munain A, Martí Massó JF.

Mov Disord. 2011 Sep;26(11):2026-31. doi: 10.1002/mds.23773. Epub 2011 May 24.

PMID:
21611983

Supplemental Content

Loading ...
Support Center